Oriel Research

Oriel ResearchOriel Research
Oriel Research

Oriel Research

Crowdsourcing genomic data to discover disease markers and therapy correlations for personalized medicine.

2017Inactive6

About

Oriel Research is a crowdsourcing initiative focused on collecting and analyzing genomic data from both healthy and sick individuals. Their primary goal is to identify disease markers and understand the correlations between various therapies and their outcomes, aiming to advance personalized medicine.
Frequently asked

What does Oriel Research do?

Oriel Research is a crowdsourcing initiative focused on collecting and analyzing genomic data from both healthy and sick individuals. Their primary goal is to identify disease markers and understand the correlations between various therapies and their outcomes, aiming to advance personalized medicine.

What is Oriel Research's revenue?

StartupHub estimates Oriel Research's annual revenue at $1.3M (range $1.1M to $2.8M, 65% confidence), based on comparable companies in the sector.

When was Oriel Research founded?

Oriel Research was founded in 2017.

What industry does Oriel Research operate in?

Oriel Research operates in Healthcare, Genomics, HealthTech, Drug Discovery, Clinical Trials, Biotech.

How many employees does Oriel Research have?

Oriel Research has approximately 6 people on record.

What is Oriel Research's current status?

Oriel Research's current operating status is: Inactive.

HEADCOUNT
6
DOMAIN RATING
0.3
Scores
Measured, not editorial
Agent Readiness
22/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Domain Rating
0/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.